SCHEMBL6587585

SCHEMBL6587585

c1ccc(-c2cncc(CN3CCCC3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 7/20 0.61
DRD4 P21917 6/20 0.61
DRD3 P35462 6/20 0.61
CHRNB2 P17787 1/20 0.54
CHRNA4 P43681 1/20 0.54
HTR1A P08908 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
PARP1 P09874 1/20 0.50
DHODH Q02127 1/20 0.50
DYRK1A Q13627 6/20 0.49
WNT1 P04628 2/20 0.49
CLK2 P49760 3/20 0.49
CLK3 P49761 3/20 0.49
HRH4 Q9H3N8 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
CHKA P35790 1/20 0.48
GSK3B P49841 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6592880 0.89 DRD2 (0.52) DRD2DRD4DRD3HTR1APARP1
Fumaric Acid SCHEMBL6592877 0.89 DRD2 (0.52) DRD2DRD4DRD3HTR1APARP1
SCHEMBL7679008 0.86 DRD2 (0.61) DRD2DRD4DRD3HTR1ADYRK1A
SCHEMBL7502588 0.85 DRD4 (0.83) DRD2DRD4DRD3HTR1A
SCHEMBL6584206 0.84 DRD2 (0.56) DRD2DRD4DRD3CHRNB2CHRNA4
SCHEMBL29204544 0.84 DRD2 (0.55) DRD2DRD4DRD3HTR1ADYRK1A
SCHEMBL30484395 0.84 DRD2 (0.55) DRD2DRD4DRD3HTR1ADYRK1A
SCHEMBL10373223 0.83 MEN1 (0.56) DRD2DRD4DRD3HTR1A
Hydrochloric Acid SCHEMBL27428269 0.82 DRD2 (0.59) DRD2DRD4DRD3HTR1ADYRK1A
Hydrochloric Acid SCHEMBL10466747 0.81 MEN1 (0.53) DRD2DRD4DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871615-B1 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS MERCK & CO INC (US) 2004-07-14 EP disclosed
US-6194581-B1 FOR TREATMENT OF DYSFUNCTION OF THE CENTRAL OR AUTONOMIC NERVOUS SYSTEMS INCLUDING DEMENTIA, COGNITIVE DISORDERS, NEURODEGENERATIVE DISORDERS, EXTRAPYRAMIDAL DISORDERS, CONVULSIVE DISORDERS, CARDIOVASCULAR DISORDERS, PAIN MERCK & CO., INC. 2001-02-27 US disclosed
US-5852041-A Substituted pyridines useful as modulators of acethylcholine receptors SIBIA NEUROSCIENCES, INC. (US) 1998-12-22 US disclosed
US-5736560-A USEFUL IN THE TREATMENT OF ALZHEIMER'S AND PARKINSONS'S DISEASES SIBIA NEUROSCIENCES, INC. (US) 1998-04-07 US disclosed
US-5585388-A Substituted pyridines useful as modulators of acetylcholine receptors SIBIA NEUROSCIENCES, INC. (US) 1996-12-17 US disclosed
WO-1996031475-A2 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1996-10-10 WO disclosed